Speeding up early drug development
Therapeutic molecules of clinical-grade quality. From 1 mg. Ready to ship.
Therapeutic Molecules Biologics ADCs Monoclonal antibodies Bispecific antibodies Reference products
aliquoted from medicines
Drug aliquots for R&D
- Immediately available
- From 1 vial per order
- 2-4 weeks lead time
- Minimum order applies
best selling products
Vedolizumab
12791714
Enfortumab Vedotin
3PA0185
Thyrotropin alfa
EY0190
Agalsidase beta
EW2122
Loncastuximab tesirine
S22E015C
Amivantamab
PES0C04
Enfortumab Vedotin
3PA0169
Teclistamab
AU1230P5
Rituximab
N7734B02
Brentuximab vedotin
12710715
Analytical data service
Explore our comprehensive suite of analytical
methods to analyze biologic molecules.
- Comprehensive Analysis Package
- Individual Analysis Package
- Taylored Analysis Package
- Therapeutic drugs as aliquots
- Multiple drug batches
- Consumable, so no license needed
- Prompt Delivery
- Fraction of the original drug price
Evidentic – fast, accurate, secure
Our products are empowering researchers worldwide
"Overall, I'm very happy with my purchase from Evidentic, and I would highly recommend them to anyone looking for high-quality products with sustainable packaging."
Tara Foley
Senior Technical Officer | Dept of Anatomy and Neuroscience
"After having great difficulty sourcing therapeutic antibodies in the small quantities required for research purposes, Evidentic has been a revelation! I have found them to be very friendly and prompt in replying to orders and queries."
Dr. Cassey McRae
Senior R&D Scientist at Avacta Life Sciences
"Evidentic gives rapid access to originator biologics and different batches. For biosimilar developers and regulators, it will shorten the time to gauge the analytical acceptance range for multiple CQAs of biotherapeutics."
Prof. Dr. Henning von Horsten
Life Science Engineering, HTW Berlin
“Evidentic was the only source that offered small aliquots of original therapeutic mAbs at an affordable price range. The aliquots came in an easy-to-use-and-store format that was apt for my research purpose.”
Ivanna Hrynchak
PhD Student ICNAS, Universidade de Coimbra
“We develop innovative and biosimilar mAbs for a global market. Evidentic’s aRMPs are a great source of cost-efficient reference products for our research and development program.”
Tom H. Jin, M.D.
Director of Process Development
"Evidentic is a new source of cost-efficient therapeutic mAbs for our immonassays. And easy to order!”
Thibault Jonckheere
CEO
"Evidentic drug aliquots have helped us speed up our antibody characterization assays and selection of clonal cell lines. An easy and reliable source!"
Prof. (emeritus) Dr. Florian Wurm
CSO & Founder
”Evidentic can supply different batches of reference products for pre-clinical research. The quick access allows for ad-hoc ordering, keeps costs down and makes a headstart possible!”